Stocks and securities in focus
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y ▼ | 5y |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 2.960% | 2.491% | 5.649% | 75.867% | 36.364% | 341.176% | 594.712% |
| Vertex Pharmaceuticals Inc. | -1.460% | 3.337% | 11.264% | 30.245% | 10.830% | 132.580% | 176.591% |
| Intra-Cellular Therapies Inc. | 2.480% | -1.626% | -11.029% | 4.131% | -7.209% | 97.712% | 431.168% |
| Cardiff Oncology Inc. | -6.570% | 3.715% | -17.791% | 114.469% | 154.559% | -50.370% | -4.286% |
| Ocular Therapeutix Inc. | -5.310% | 9.091% | 16.200% | -4.803% | 35.558% | -50.966% | 87.661% |
| Gritstone Oncology Inc | -1.880% | 8.269% | 11.957% | -57.508% | -58.423% | -89.666% | - |
| Agenus Inc. | -1.970% | - | - | - | - | - | - |